pgd, Autor bei Psychedelische Gesellschaft Deutschland

The Feds Finally Admit That Psychedelics Are Medicine

von pgd | Jan 22, 2020 | International

The heads of the FDA and NIH co-authored a letter acknowledging the therapeutic potential of LSD, MDMA, psilocybin, and ketamine. The heads of the Food and Drug Administration (FDA) and the National Institutes of Health (NIH) have acknowledged the therapeutic...

A Single Dose of Psilocybin Mushrooms Can Reduce Anxiety for Nearly Five Years

von pgd | Jan 22, 2020 | Forschung

A 2016 study found that a single dose of shrooms can significantly reduce cancer patients‘ fear of death, and a new follow-up study has found that these benefits can last for years. Nearly five years ago, a team of researchers conducted a landmark trial...

New research confirms lingering mood benefit of psychedelics – Neuroscience News

von pgd | Jan 22, 2020 | Forschung

Summary: Psychedelics, such as psilocybin, provide lasting improvements in mood and feelings of social connectedness after the effect of the drug has worn off. Source: Yale People who had recently used psychedelics such as psilocybin report a sustained improvement in...

Johns Hopkins Scientists Give Psychedelics the Serious Treatment – Scientific American

von pgd | Jan 22, 2020 | International

The first research center of its kind in the country is bringing renewed rigor to the investigation of the drugs’ therapeutic uses. Psychedelic drugs—once promising research subjects that were decades ago relegated to illicit experimentation in dorm rooms—have been...

scobel – Drogen als Medizin – 3sat-Mediathek

von pgd | Jan 22, 2020 | Aktuelles

Von der illegalen Droge zum Heilmittel: Werden psychedelische Substanzen wie LSD oder „Zauberpilze“ schon bald als Arzneien gegen Depressionen, Angststörungen und Schmerzen eingesetzt? Quelle: scobel – Drogen als Medizin –...

« Ältere Einträge